Rodman and Renshaw Upcoming PDUFA Dates
11/26/2009, Theravance, Inc. (THRX, Not Rated), Telavancin, Nosocomial Pneumonia (Hospital-Acquired
Pneumonia) Caused By Gram-Positive Bacteria, Such As Methicillin-Resistant Staphylococcus aureus (MRSA)
(Confirmed)
12/01/2009, Dyax Corp. (DYAX, Not Rated), DX-88 (Ecallantide), Hereditary Angioedema (HAE) (Confirmed)
12/09/2009, Santarus, Inc. (SNTS, Not Rated)/ Schering-Plough Corporation (SGP, Not Rated), Zegerid OTC
(Omeprazole/Sodium Bicarbonate), Frequent Heartburn (Estimated)
12/11/2009, Vion Pharmaceuticals, Inc. (VION, Not Rated), Onrigin (Laromustine)/Formerly Cloretazine, De Novo
Poor-Risk Acute Myeloid Leukemia (AML) In Patients Sixty Years Of Age Or Older
12/18/2009, Schering-Plough Corporation (SGP, Not Rated), Saphris (Asenapine), Schizophrenia, Bipolar
Disorder. (estimated)
Dec 2009, Genzyme Corporation (GENZ Not Rated), Genzyme Oncology Clolar (Clofarabine), Acute
Myelogenous Leukemia (AML) In Previously Untreated Adults Aged 60 years Or Older (Confirmed)
Fall 2009, Hemispherx BioPharma, Inc (HEB, Not Rated), Ampligen (Double Stranded RNA Toll-Like Receptor-3
Agonist), Chronic Fatigue Syndrome (CFS)/Myalgic Encephalomyelitis(ME)
01/16/2010, MannKind Corporation (MNKD, Market Outperform), Afresa (Technosphere Inhaled Insulin System),
Non-Insulin Dependent Diabetes Mellitus (NIDDM)/Type 2 Diabetes, Insulin Dependent Diabetes Mellitus
(IDDM)/Type 1 Diabetesv (estimated)
01/22/2010, SkyePharma PLC (ADR) (SKYEY, Not Rated)/ Abbott Laboratories (ABT, Not Rated), Flutiform
(Formoterol/Fluticasone), Maintenance Treatment Of Asthma In Patients 12 Years Of Age and Older (estimated)
02/09/2010, GlaxoSmithKline plc (ADR) (GSK. Not Rated)/ XenoPort, Inc. (XNPT, Market Outperform), Solzira
(Gabapentin Prodrug)/XP13512, Restless Leg Syndrome (RLS) (Estimated)
Upcoming Scientific
